The company intends to use the funds for the continued development of its minimally invasive products.

Founded in 2008 and led by Dennis Wahr, M.D., president and CEO, Holaira is working on a novel catheter-based system for a procedure called Targeted Lung Denervation, that has the potential to make breathing easier for patients with chronic obstructive pulmonary disease (COPD).